<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/468"/><api:result><api:object category="publication" id="468" last-affected-when="2024-03-16T18:04:47.29+00:00" last-modified-when="2024-03-16T18:04:47.29+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/468" created-when="2010-05-17T13:46:20.897+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-07-30</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="4200250" source-id="28" source-name="eprints" source-display-name="White Rose Research Online" id-at-source="85499" last-modified-when="2022-12-28T18:22:10.803+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Small-cell lung cancer (SCLC) can produce numerous mitogenic neuropeptides, which are not found in normal respiratory epithelium. Arginine vasopressin is detected in up to two-thirds of SCLC tumours whereas normal physiological expression is essentially restricted to the hypothalamus. This presents the opportunity to identify elements of the gene promoter which could be exploited for SCLC-specific targeting. A series of human vasopressin 5′ promoter fragments (1048 bp, 468 bp and 199 bp) were isolated and cloned upstream of a reporter gene. These were transfected into a panel of ten cell lines, including SCLC with high or low endogenous vasopressin transcription, non-SCLC and bronchial epithelium. All these fragments directed reporter gene expression in the five SCLC cell lines, but had negligible activity in the control lines. The level of reporter gene expression reflected the level of endogenous vasopressin production, with up to 4.9-fold (s.d. 0.34) higher activity than an SV40 promoter. The elements required for this strong, restricted, SCLC-specific promoter activity are contained within the 199-bp fragment. Further analysis of this region indicated involvement of E-box transcription factor binding sites, although tumour-specificity was retained by a 65-bp minimal promoter fragment. These data show that a short region of the vasopressin promoter will drive strong expression in SCLC in vitro and raise the possibility of targeting gene therapy to these tumours.</api:text></api:field><api:field name="acceptance-date" type="date" display-name="Date of acceptance"><api:date><api:day>17</api:day><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Coulson</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stanley</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690623</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690623"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690623"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>12</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>vasopressin</api:keyword><api:keyword>promoter</api:keyword><api:keyword>SCLC</api:keyword><api:keyword>transcription</api:keyword><api:keyword>tumour-specific</api:keyword><api:keyword>enhancer</api:keyword><api:keyword>thymidine kinase gene</api:keyword><api:keyword>anti-diuretic hormone</api:keyword><api:keyword>oxytocin genes</api:keyword><api:keyword>messenger-RNA</api:keyword><api:keyword>expression</api:keyword><api:keyword>carcinoma</api:keyword><api:keyword>lines</api:keyword><api:keyword>glucocorticoids</api:keyword><api:keyword>transcription</api:keyword><api:keyword>sequence</api:keyword></api:keywords></api:field><api:field name="notes" type="text" display-name="Other information"><api:text>© 1999 Cancer Research Campaign. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>30</api:day><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1935</api:begin-page><api:end-page>1944</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>30</api:day><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="public-url" type="text" display-name="Public URL"><api:text>https://eprints.whiterose.ac.uk/id/eprint/85499</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Cancer Research UK</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>https://dx.doi.org/10.1038/sj.bjc.6690623</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>28</api:day><api:month>4</api:month><api:year>2015</api:year></api:date></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>1</api:day><api:month>8</api:month><api:year>2016</api:year></api:date></api:field><api:field name="repository-status" type="text" display-name="Availability"><api:text>Public</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field><api:files><api:file proprietary-id="https://eprints.whiterose.ac.uk/id/file/583128"><api:filename>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer..pdf</api:filename><api:file-url>https://eprints.whiterose.ac.uk/85499/1/Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer..pdf</api:file-url><api:extension>pdf</api:extension><api:file-size>223410</api:file-size><api:mime-type>application/pdf</api:mime-type><api:checksum algorithm="md5">76E980B4CBEE6E1C321C71513B19EED7</api:checksum><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="1806257" source-id="1" source-name="manual" source-display-name="Manual" id-at-source="C01E4F86-898B-4780-8DFD-F9EC3C359824" last-modified-when="2016-08-01T11:01:42.71+01:00"><api:verification-status>verified</api:verification-status><api:native><api:field name="acceptance-date" type="date" display-name="Date of acceptance"><api:date><api:day>17</api:day><api:month>2</api:month><api:year>1999</api:year></api:date></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Coulson</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stanley</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="c-goldoa" type="boolean" display-name="Gold Open Access?"><api:boolean>true</api:boolean></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690623</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690623"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690623"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>12</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>30</api:day><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1935</api:begin-page><api:end-page>1944</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>30</api:day><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher-licence" type="text" display-name="Publisher licence"><api:text>CC BY-NC-SA</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>1</api:day><api:month>8</api:month><api:year>2016</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="1488695" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1038/sj.bjc.6690623" last-modified-when="2023-05-20T00:45:36.137+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Coulson</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stanley</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690623</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690623"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690623"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>12</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>30</api:day><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1935</api:begin-page><api:end-page>1944</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1038/sj.bjc.6690623</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>5</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="94470" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0032802285" last-modified-when="2023-05-09T21:59:21.78+01:00"><api:citation-count>23</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Small-cell lung cancer (SCLC) can produce numerous mitogenic neuropeptides, which are not round in normal respiratory epithelium. Arginine vascopressin is detected in up to two-thirds of SCLC tumours whereas normal physiological expression is fssentialy restricted to the hypothalamus. This presents the opportunity to identify elements of the gene promote: which could be exploited for SCLC-specific targeting. A series of human vasopressin 5' promoter fragments (1048 bp, 468 bp and 199 bp) were isolated and cloned upstream of a reporter gene. These were transfected into a panel of ten cell lines, including SCLC with high or low endogenous vasopressin transcription, non-SCLC and bronchial epithelium. All these fragments directed reporter gene expression in the five SCLC cell lines, but had negligible activity in the control lines. The level of reporter gene expression reflected the level or endogenous, vasopressin production, with up to 4.9-fold (s.d. 0.34) higher activity than an SV40 promoter. The elements required for this strong, restricted, SCLC-specific promoter activity are contained within the 199-bp fragment. Further analysis of this region indicated involvement of E-box transcription factor binding sites; although tumour-specificity was retained by a 65-bp minimal promoter fragment. These data show that a short region of the vasopressin promoter will drive strong expression in SCLC in vitro and raise the possibility of targeting gene therapy to these tumours.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Coulson</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Nottingham</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005864041</api:identifier></api:identifiers></api:person><api:person><api:last-name>Stanley</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Nottingham</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57196909325</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Nottingham</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005024157</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690623</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690623"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690623"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10471042</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>12</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1935</api:begin-page><api:end-page>1944</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>28</api:day><api:month>8</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="468" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10471042" last-modified-when="2022-11-22T20:55:54.053+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Small-cell lung cancer (SCLC) can produce numerous mitogenic neuropeptides, which are not found in normal respiratory epithelium. Arginine vasopressin is detected in up to two-thirds of SCLC tumours whereas normal physiological expression is essentially restricted to the hypothalamus. This presents the opportunity to identify elements of the gene promoter which could be exploited for SCLC-specific targeting. A series of human vasopressin 5' promoter fragments (1048 bp, 468 bp and 199 bp) were isolated and cloned upstream of a reporter gene. These were transfected into a panel of ten cell lines, including SCLC with high or low endogenous vasopressin transcription, non-SCLC and bronchial epithelium. All these fragments directed reporter gene expression in the five SCLC cell lines, but had negligible activity in the control lines. The level of reporter gene expression reflected the level of endogenous vasopressin production, with up to 4.9-fold (s.d. 0.34) higher activity than an SV40 promoter. The elements required for this strong, restricted, SCLC-specific promoter activity are contained within the 199-bp fragment. Further analysis of this region indicated involvement of E-box transcription factor binding sites, although tumour-specificity was retained by a 65-bp minimal promoter fragment. These data show that a short region of the vasopressin promoter will drive strong expression in SCLC in vitro and raise the possibility of targeting gene therapy to these tumours.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Coulson</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">CRC Department of Clinical Oncology, University of Nottingham, City Hospital, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Stanley</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10471042</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690623</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690623"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690623"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC2374275</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>12</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Arginine Vasopressin</api:keyword><api:keyword scheme="mesh">Carcinoma, Small Cell</api:keyword><api:keyword scheme="mesh">Chloramphenicol O-Acetyltransferase</api:keyword><api:keyword scheme="mesh">Enhancer Elements, Genetic</api:keyword><api:keyword scheme="mesh">Gene Expression Regulation, Neoplastic</api:keyword><api:keyword scheme="mesh">Genes, Reporter</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hypothalamus</api:keyword><api:keyword scheme="mesh">Lung Neoplasms</api:keyword><api:keyword scheme="mesh">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh">Restriction Mapping</api:keyword><api:keyword scheme="mesh">Reverse Transcriptase Polymerase Chain Reaction</api:keyword><api:keyword scheme="mesh">Transcription, Genetic</api:keyword><api:keyword scheme="mesh">Transfection</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1935</api:begin-page><api:end-page>1944</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>6690623</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>21</api:day><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="881867" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10471042" last-modified-when="2023-11-21T18:55:31.937+00:00"><api:citation-count>16</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Small-cell lung cancer (SCLC) can produce numerous mitogenic neuropeptides, which are not found in normal respiratory epithelium. Arginine vasopressin is detected in up to two-thirds of SCLC tumours whereas normal physiological expression is essentially restricted to the hypothalamus. This presents the opportunity to identify elements of the gene promoter which could be exploited for SCLC-specific targeting. A series of human vasopressin 5' promoter fragments (1048 bp, 468 bp and 199 bp) were isolated and cloned upstream of a reporter gene. These were transfected into a panel of ten cell lines, including SCLC with high or low endogenous vasopressin transcription, non-SCLC and bronchial epithelium. All these fragments directed reporter gene expression in the five SCLC cell lines, but had negligible activity in the control lines. The level of reporter gene expression reflected the level of endogenous vasopressin production, with up to 4.9-fold (s.d. 0.34) higher activity than an SV40 promoter. The elements required for this strong, restricted, SCLC-specific promoter activity are contained within the 199-bp fragment. Further analysis of this region indicated involvement of E-box transcription factor binding sites, although tumour-specificity was retained by a 65-bp minimal promoter fragment. These data show that a short region of the vasopressin promoter will drive strong expression in SCLC in vitro and raise the possibility of targeting gene therapy to these tumours.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">CRC Department of Clinical Oncology, University of Nottingham, City Hospital, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Coulson</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0003-2191-2001</api:identifier></api:identifiers></api:person><api:person><api:last-name>Stanley</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-1118-0831</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690623</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690623"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690623"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10471042</api:identifier><api:identifier scheme="pmc">PMC2374275</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>12</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British journal of cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Hypothalamus</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Carcinoma, Small Cell</api:keyword><api:keyword scheme="mesh">Lung Neoplasms</api:keyword><api:keyword scheme="mesh">Chloramphenicol O-Acetyltransferase</api:keyword><api:keyword scheme="mesh">Restriction Mapping</api:keyword><api:keyword scheme="mesh">Transfection</api:keyword><api:keyword scheme="mesh">Reverse Transcriptase Polymerase Chain Reaction</api:keyword><api:keyword scheme="mesh">Transcription, Genetic</api:keyword><api:keyword scheme="mesh">Gene Expression Regulation, Neoplastic</api:keyword><api:keyword scheme="mesh">Genes, Reporter</api:keyword><api:keyword scheme="mesh">Arginine Vasopressin</api:keyword><api:keyword scheme="mesh">Enhancer Elements, Genetic</api:keyword><api:keyword scheme="mesh">Promoter Regions, Genetic</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Open Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1935</api:begin-page><api:end-page>1944</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher-licence" type="text" display-name="Publisher licence"><api:text>CC BY</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>2</api:day><api:month>9</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>research-article</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field><api:files><api:file proprietary-id="https://www.nature.com/articles/6690623.pdf"><api:file-url>https://www.nature.com/articles/6690623.pdf</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file><api:file proprietary-id="https://europepmc.org/articles/PMC2374275?pdf=render"><api:file-url>https://europepmc.org/articles/PMC2374275?pdf=render</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="2708413" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1053160883" last-modified-when="2024-03-16T18:04:47.323+00:00"><api:citation-count>25</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>3</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Coulson</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Nottingham</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nottingham City Hospital</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01315470037.06</api:identifier></api:identifiers></api:person><api:person><api:last-name>Stanley</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Nottingham</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nottingham City Hospital</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Nottingham</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nottingham City Hospital</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0672175303.65</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690623</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690623"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690623"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10471042</api:identifier><api:identifier scheme="pmc">PMC2374275</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>12</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc">Lung Cancer</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="rcdc">Rare Diseases</api:keyword><api:keyword scheme="rcdc">Lung</api:keyword><api:keyword scheme="rcdc">Genetics</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-hc">Cancer</api:keyword><api:keyword scheme="mesh">Arginine Vasopressin</api:keyword><api:keyword scheme="mesh">Carcinoma, Small Cell</api:keyword><api:keyword scheme="mesh">Chloramphenicol O-Acetyltransferase</api:keyword><api:keyword scheme="mesh">Enhancer Elements, Genetic</api:keyword><api:keyword scheme="mesh">Gene Expression Regulation, Neoplastic</api:keyword><api:keyword scheme="mesh">Genes, Reporter</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hypothalamus</api:keyword><api:keyword scheme="mesh">Lung Neoplasms</api:keyword><api:keyword scheme="mesh">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh">Restriction Mapping</api:keyword><api:keyword scheme="mesh">Reverse Transcriptase Polymerase Chain Reaction</api:keyword><api:keyword scheme="mesh">Transcription, Genetic</api:keyword><api:keyword scheme="mesh">Transfection</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>30</api:day><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Hybrid OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1935</api:begin-page><api:end-page>1944</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.51</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="240446" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000081900400010" last-modified-when="2024-03-14T05:36:42.86+00:00"><api:citation-count>22</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Coulson</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stanley</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000081900400010&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690623</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690623"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690623"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">224LK</api:identifier><api:identifier scheme="pubmed">10471042</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>12</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRITISH JOURNAL OF CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>vasopressin</api:keyword><api:keyword>promoter</api:keyword><api:keyword>SCLC</api:keyword><api:keyword>transcription</api:keyword><api:keyword>tumour-specific</api:keyword><api:keyword>enhancer</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1935</api:begin-page><api:end-page>1944</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="23242" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000081900400010" last-modified-when="2014-07-25T11:03:30.927+01:00"><api:citation-count>18</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Coulson</api:last-name><api:initials>JM</api:initials><api:first-names>JM</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stanley</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>12</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRIT J CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>vasopressin</api:keyword><api:keyword>promoter</api:keyword><api:keyword>SCLC</api:keyword><api:keyword>transcription</api:keyword><api:keyword>tumour-specific</api:keyword><api:keyword>enhancer</api:keyword><api:keyword>THYMIDINE KINASE GENE</api:keyword><api:keyword>ANTI-DIURETIC HORMONE</api:keyword><api:keyword>OXYTOCIN GENES</api:keyword><api:keyword>MESSENGER-RNA</api:keyword><api:keyword>EXPRESSION</api:keyword><api:keyword>CARCINOMA</api:keyword><api:keyword>LINES</api:keyword><api:keyword>GLUCOCORTICOIDS</api:keyword><api:keyword>TRANSCRIPTION</api:keyword><api:keyword>SEQUENCE</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1935</api:begin-page><api:end-page>1944</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword origin="record-data" source="eprints">vasopressin</api:keyword><api:keyword origin="record-data" source="eprints">promoter</api:keyword><api:keyword origin="record-data" source="eprints">SCLC</api:keyword><api:keyword origin="record-data" source="eprints">transcription</api:keyword><api:keyword origin="record-data" source="eprints">tumour-specific</api:keyword><api:keyword origin="record-data" source="eprints">enhancer</api:keyword><api:keyword origin="record-data" source="eprints">thymidine kinase gene</api:keyword><api:keyword origin="record-data" source="eprints">anti-diuretic hormone</api:keyword><api:keyword origin="record-data" source="eprints">oxytocin genes</api:keyword><api:keyword origin="record-data" source="eprints">messenger-RNA</api:keyword><api:keyword origin="record-data" source="eprints">expression</api:keyword><api:keyword origin="record-data" source="eprints">carcinoma</api:keyword><api:keyword origin="record-data" source="eprints">lines</api:keyword><api:keyword origin="record-data" source="eprints">glucocorticoids</api:keyword><api:keyword origin="record-data" source="eprints">transcription</api:keyword><api:keyword origin="record-data" source="eprints">sequence</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Arginine Vasopressin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Carcinoma, Small Cell</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Chloramphenicol O-Acetyltransferase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Enhancer Elements, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Gene Expression Regulation, Neoplastic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Genes, Reporter</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Hypothalamus</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Lung Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Restriction Mapping</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Reverse Transcriptase Polymerase Chain Reaction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Transcription, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Transfection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Hypothalamus</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Carcinoma, Small Cell</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Lung Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Chloramphenicol O-Acetyltransferase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Restriction Mapping</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Transfection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Reverse Transcriptase Polymerase Chain Reaction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Transcription, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Gene Expression Regulation, Neoplastic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Genes, Reporter</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Arginine Vasopressin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Enhancer Elements, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Promoter Regions, Genetic</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Lung Cancer</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Rare Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Lung</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Genetics</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Arginine Vasopressin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Carcinoma, Small Cell</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Chloramphenicol O-Acetyltransferase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Enhancer Elements, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Gene Expression Regulation, Neoplastic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Genes, Reporter</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Hypothalamus</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Lung Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Promoter Regions, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Restriction Mapping</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Reverse Transcriptase Polymerase Chain Reaction</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Transcription, Genetic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Transfection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Cells, Cultured</api:keyword><api:keyword origin="record-data" source="wos-lite">vasopressin</api:keyword><api:keyword origin="record-data" source="wos-lite">promoter</api:keyword><api:keyword origin="record-data" source="wos-lite">SCLC</api:keyword><api:keyword origin="record-data" source="wos-lite">transcription</api:keyword><api:keyword origin="record-data" source="wos-lite">tumour-specific</api:keyword><api:keyword origin="record-data" source="wos-lite">enhancer</api:keyword><api:keyword origin="record-data" source="wos">vasopressin</api:keyword><api:keyword origin="record-data" source="wos">promoter</api:keyword><api:keyword origin="record-data" source="wos">SCLC</api:keyword><api:keyword origin="record-data" source="wos">transcription</api:keyword><api:keyword origin="record-data" source="wos">tumour-specific</api:keyword><api:keyword origin="record-data" source="wos">enhancer</api:keyword><api:keyword origin="record-data" source="wos">THYMIDINE KINASE GENE</api:keyword><api:keyword origin="record-data" source="wos">ANTI-DIURETIC HORMONE</api:keyword><api:keyword origin="record-data" source="wos">OXYTOCIN GENES</api:keyword><api:keyword origin="record-data" source="wos">MESSENGER-RNA</api:keyword><api:keyword origin="record-data" source="wos">EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">CARCINOMA</api:keyword><api:keyword origin="record-data" source="wos">LINES</api:keyword><api:keyword origin="record-data" source="wos">GLUCOCORTICOIDS</api:keyword><api:keyword origin="record-data" source="wos">TRANSCRIPTION</api:keyword><api:keyword origin="record-data" source="wos">SEQUENCE</api:keyword><api:keyword scheme="for" origin="issn-inferred">1112 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for" origin="issn-inferred">1117 Public Health and Health Services</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Oncology &amp; Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3211 Oncology and carcinogenesis</api:keyword></api:keywords></api:all-labels><api:journal issn="0007-0920" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662" title="British Journal of Cancer"><api:records><api:record source-name="summary"><api:title>British Journal of Cancer</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/468/relationships"/></api:object></api:result></api:response>